SmartMoney Ventures Podcast

The SmartMoney Ventures Podcast highlights leaders in the global ecosystem of venture capital, entrepreneurship and innovation across all industries. We give you access to insights from top investors and innovators that most people can’t access, and the only reason they take my calls is because I’ve been in the trenches with them for over 25 years.

All Episodes

SmartMoney Ventures Podcast

SMV5: Dr. Michael Triplett, CEO of Myonexus Therapeutics on its sale to Sarepta

June 02, 2021 • Jeff (J.D.) Davids • Season 1 • Episode 5

This episode of the SmartMoney Ventures Podcast features Dr. Michael Triplett, CEO of Myonexus Therapeutics who, along with co-founder Dr. Louise Rodino-Klapac, successfully completed a 9 figure exit event before securing Series A financing.

The story illustrates how successful tech transfer and strategic positioning resulted in the establishment of a new Gene Therapy Center of Excellence creating over 100 new jobs while transforming Muscular Dystrophy patient treatments.

Prior to co-founding Myonexus, Michael held leadership positions at Proctor & Gamble, Battelle Memorial Institute and Ventaira Pharmaceuticals among others.

In this episode, you will learn:

How to get a 9 figure exit before your Series A financing
How Technology Transfer is transforming the Heartland Region
Why resilience is a big part of entrepreneurial psychology
Sage advice for technical & scientific founders
How a Gene Therapy Center of Excellence was established in Central Ohio

Dr. Triplett holds both a bachelor’s degree and a Ph.D. in Chemical Engineering from THE Ohio State University graduating Summa Cum Laude.